Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [ÀÇÇнŹ®] ¾à±¹¿¡¼­µµ Ä¡¸ÅȯÀÚ°ü¸®°¡ ÇÊ¿äÇÏ´Ù
³»   ¿ë

¾à±¹¿¡¼­µµ Ä¡¸ÅȯÀÚ°ü¸®°¡ ÇÊ¿äÇÏ´Ù


Ä¡¸ÅȯÀÚÀ¯º´·ü ²ÙÁØÈ÷ »ó½Â¡¦¿À´Â 2025³â Ä¡¸ÅÀα¸ 100¸¸ ¸í Ãʰú ¿¹»ó


[ÀÇÇнŹ®¡¤Àϰ£º¸»ç=±è¹ÎÁö ±âÀÚ] ±Þ¼ÓÇÑ °í·ÉÈ­¿¡ µû¶ó Ä¡¸ÅÀ¯º´·üÀÌ ±Þ°ÝÈ÷ Áõ°¡Çϴ °¡¿îµ¥ Ä¡¸Å°¡ »çȸÀûÀΠ¹®Á¦·Î Àνĵǰí ÀÖ´Ù. ÀÌ¿¡ µû¶ó Áö¿ª»çȸ µ¹º½ÀÇ °³³ä¿¡¼­ ¾à±¹ÀÇ ¿ªÇÒÀ» Á¦°íÇØ¾ß ÇѴٴ ÁÖÀåÀÌ Á¦±âµÇ°í ÀÖ´Ù.

Áö³­ÇØ Åë°èûÀÌ ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é, Çѱ¹ÀÇ °í·ÉÀα¸ÀÇ ºñÀ²Àº ¸Å¿ì ºü¸¥ ¼Óµµ·Î Áõ°¡ÇØ ¿À´Â 2045³â¿¡´Â 65¼¼ ÀÌ»ó °í·ÉÀα¸ ºñÁßÀÌ °¡Àå ³ôÀº ±¹°¡°¡ µÉ °ÍÀ¸·Î Àü¸ÁµÈ´Ù. Æ¯È÷,  ÇöÀç 65¼¼ ÀÌ»óÀÇ 10.3%ÀΠ76¸¸ ¸í¿¡ ´ÞÇϴ ġ¸ÅÀα¸°¡ ¿À´Â 2025³â¿¡ 100¸¸ ¸íÀ» ³Ñ¾î¼³ °ÍÀ¸·Î ¿¹»óµÈ´Ù.

¼¼°è¿Í ±¹³»ÀÇ °í·ÉÀα¸ ±¸¼ººñ ºñÀ²(Åë°èû, 2019³â)

ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò°¡ Ä¡¸Å³ëÀÎÀ» ´ë»óÀ¸·Î Æ¯È­µÈ ¾à±¹ Ä¡¸Å°ü¸®¼­ºñ½º ¸ðµ¨ Á¦½Ã¸¦ ¸ñÀûÀ¸·Î °ü·ÃÇÑ ¿Ü±¹ »ç·Ê¸¦ Á¶»çÇÑ ¿¬±¸°á°ú¿¡ µû¸£¸é, Á¤ºÎ´Â Áö³­ 2017³â ¡®Ä¡¸Å±¹°¡Ã¥ÀÓÁ¦¡¯¸¦ µµÀÔÇØ Àü±¹ 256°³¼ÒÀÇ Ä¡¸Å¾È½É¼¾Å͸¦ ¼³¸³Çß´Ù. ±¹°¡Â÷¿ø¿¡¼­ Ä¡¸Å ±Øº¹À» À§ÇÑ ÁßÀå±â °èȹÀ» ¼ö¸³Çϰí Ä¡¸ÅȯÀÚ¿¡ ´ëÇÑ È¿°úÀûÀΠ°Ç°­°ü¸®¿Í µ¹º½ ºÎ´ãÀ» ¿ÏÈ­Çϱâ À§Çؼ­´Ù.

ÇÏÁö¸¸ ´Ù¸¥ ±¹°¡¿¡ ºñÇØ Áö¿ª¾à±¹°úÀÇ Çù·ÂüÁ¦ ±¸ÃàÀÌ ¹ÌÈíÇϴٴ ¸ñ¼Ò¸®°¡ Á¦±âµÇ°í ÀÖ´Ù.

ÀϺ»ÀÇ °æ¿ì Ä¡¸ÅÁ¤Ã¥ ÃßÁø Á¾ÇÕÀü·«ÀΠ¡®½Å¿À·»ÁöÇ÷£¡¯À» ÅëÇØ Ä¡¸Å°¡ ÀǽɵǴ »ç¶÷À» Á¶±â¿¡ ¹ß°ßÇØ ÁÖÄ¡ÀÇ µî°ú ¿¬°èÇØ ´ëÀÀÇÒ ¼ö ÀÖµµ·Ï Çϴ ġ¸ÅÃʱâÁýÁß Áö¿øÆÀ¿¡ ¾à»ç¸¦ Æ÷ÇÔ½Ã۰í ÀÖ´Ù. 

¼¼ºÎÀûÀ¸·Î »ìÆìº¸¸é, ¾Æ¿À¸ð¸®ÇöÀ̳ª ¾ß¸¶³ª½ÃÇöÀÇ °æ¿ì ¡®°Ç°­ °£È£ ±æ°Å¸® »ó´ã ¾à±¹¡¯À» ¿î¿µÇØ ¾à±¹¿¡¼­ Ä¡¸Å ¼¿ÇÁüũ¸¦ ÇÒ ¼ö ÀÖµµ·Ï Çϰí ÀÖ´Ù. ÈÄÄí½Ã¸¶ÇöÀº ¾à±¹¿¡ ¡®Ä¡¸Å´ëÀÀ¾à±¹¡¯ ½ºÆ¼Ä¿¸¦ ºÎÂøÇØ Ä¡¸Å³ëÀÎÀǠƯ¼ºÀ» °í·ÁÇØ ´ëÀÀÇϵµ·Ï Çϰí ÀÖ´Ù.  

¿µ±¹ ¿ª½Ã Ä¡¸ÅȯÀÚ °ü¸®¿¡¼­ ¾à±¹°ú ¾à»ç°¡ ¿ªÇÒÀ» ¼öÇàÇϰí ÀÖ´Ù.

¸ÕÀú ¾à±¹È¯°æÀ» Á¶¼º ¹× ¾È³»Ç¥Áö, Á¶¸í, ¹Ù´ÚÀç¿¡ ´ëÇÑ Áöħ¿¡ µû¶ó ¿î¿µÇØ Ä¡¸Åģȭ¾à±¹(Dementia Friendly Pharmacy)·Î¼­ Ä¡¸Å¸¦ °¡Áø È¯ÀÚµéÀÇ Á¢±Ù¼ºÀÌ ³ô¾ÆÁú ¼ö ÀÖµµ·Ï Çß´Ù. ¶ÇÇÑ ¾à»ç¿Í ¾à±¹ Á¾¾÷¿øÀÌ Ä¡¸Å È¯ÀÚ¿¡°Ô ÀûÀýÇÑ ¼­ºñ½º¸¦ Á¦°øÇÒ ¼ö ÀÖ°Ô²û È¯ÀÚÀÀ´ë±³À°µµ ½Ç½ÃÇϰí ÀÖ´Ù.

À̿͠ÇÔ²² Ä¡¸Å¾È½É¸¶À»(Dementia Friendly Community)¿Í Áö¿ª¾à»çÀ§¿øÈ¸°¡ Ä¡¸Å Çù·Âü·Î¼­ ¿ªÇÒÀ» ¼öÇàÇÒ ¼ö ÀÖµµ·Ï ¾à»çµé°ú ¾à±¹½ºÅÂÇÁ°¡ Ä¡¸Å Ä£È­ ÈÆ·ÃÀ» ¹Þ°í ÀÖ´Ù.

ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¹ÚÇý°æ ¼ÒÀåÀº ¡°´Ù¸¥ ³ª¶ó¿¡¼­´Â ÀÌó·³ ³ë·ÉÈ­ ½Ã´ë¿¡ ±Þ°ÝÈ÷ Áõ°¡Çϴ ġ¸ÅȯÀÚ °ü¸®¸¦ À§ÇØ Áö¿ª»çȸÀÇ ¾à±¹ ¹× ¾à»çµéÀÌ Áß¿äÇÑ ¿ªÇÒÀ» ¼öÇàÇϰí ÀÖ´Ù¡±¸é¼­µµ ¡°´Ù¸¸, ¿ì¸®³ª¶ó´Â 2017³â Ä¡¸Å±¹°¡°ü¸®Á¦°¡ ½ÃÇàµÈ ÀÌ·¡ ¾ÆÁ÷±îÁö ¾à±¹ÀÇ ¿ªÇÒÀ» Ã£Áö ¸øÇϰí ÀÖ´Ù¡±°í ¼³¸íÇß´Ù.

À̾°µû¶ó¼­ Äڷγª19¿Í °°Àº °¨¿°º´ ´ëÀÀ »óȲ¿¡¼­ »Ó¸¸ ¾Æ´Ï¶ó, »ó½ÃÀûÀ̰í È¿À²ÀûÀΠÁö¿ª»çȸÅëÇÕµ¹º½ Ã¼°è ±¸ÃàÀÇ ÀÏȯÀ¸·Î¼­ ¾à±¹¿¡¼­ÀÇ Ä¡¸Å°ü¸® ¼­ºñ½º ¸ðµ¨ °³¹ßÀÌ ÀÌ·ïÁ®¾ß ÇÒ ¶§¡±¶ó°í °­Á¶Çß´Ù. 

±è¹ÎÁö ±âÀÚ  mjkim@bosa.co.kr


http://www.bosa.co.kr/news/articleView.html?idxno=2136925

 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
92 [¸ÞµðÆÄ³ª´º½º]'Äڷγª19 ´ëÀÀ¡¤ÅëÇÕµ¹º½' ´Ù·é ÀǾàǰÁ¤Ã¥¿¬±¸ ¹ß°£  ±è¼±Èñ 2021-01-19 6
91 [¾à»ç°ø·Ð] ¾à±¹ °ÅÁ¡ Àڻ쿹¹æ»ç¾÷, »ý¸íÁöÅ´ÀÌ ¿ªÇÒ 'ÅåÅå'  ±è¼±Èñ 2021-01-19 6
90 [µ¥Àϸ®ÆÊ] ÀϺ»¾à±¹ÀÇ ÁøÈ­¡¦Ä«µå·Î 'Áߺ¹Åõ¾à¡¤³²Àº ¾à °ü¸®±îÁö'  ±è¼±Èñ 2021-01-19 9
89 [´ëÇѾà»çÀú³Î] ¼¼ÀÌÇÁ¾à±¹¡¤¹æ¹®¾à·á µî Ȱµ¿ Áö¼Ó Áõ°¡ ÀÌÁö¿¬ 2021-01-19 4
88 [´ëÇѾà»çÀú³Î] ¾à±¹ ó¹æÁýÁßµµ º¯È­¿Í ¾à±¹¾à»çÀÇ »çȸÀû ¿ªÇÒ Ãß±¸ ÀÌÁö¿¬ 2021-01-13 49
87 [´ëÇѾà»çÀú³Î] ÀåÁ¡Àº Ű¿ì°í ´ÜÁ¡Àº ¾ø¾Ö´Â ±³À°¹æ¹ýÀº? ÀÌÁö¿¬ 2021-01-06 84
86 [´ëÇѾà»çÀú³Î] 'Àڱ⠹ݿµ ¾ç½Ä' ÅëÇØ ¾à±¹ Àü¹®°¡ ±âÁØ ÆÄ¾Ç ÀÌÁö¿¬ 2020-12-29 83
85 [´ëÇѾà»çÀú³Î] CPD °³³ä µîÀå 80³â, ¿ì¸®³ª¶ó´Â ¾ÆÁ÷¡¦ ÀÌÁö¿¬ 2020-12-22 94
84 ¹Ì±¹¡¤¿µ±¹ ¾à»ç, ¿Â¶óÀÎÀ¸·Î ¾î¶»°Ô °øºÎÇϳª ±è¼±Èñ 2020-12-16 96
83 ÀǾàǰÁ¤Ã¥¿¬ "¿Â¶óÀÎ ¿¬¼ö±³À°¿¡ CPD µµÀÔÇØ¾ß" ±è¼±Èñ 2020-12-16 93
82 [´ëÇѾà»çÀú³Î] CPD °³³ä µîÀå 80³â, ¿ì¸®³ª¶ó´Â ¾ÆÁ÷¡¦ ÀÌÁö¿¬ 2020-12-16 81
81 [´ëÇѾà»çÀú³Î] Áö¿ª ¿©°Ç ¸ÂÃá 'Ä¡¸Å¾È½É¸¶À»'+'Ä¡¸Å¾È½É¾à±¹' ¿î¿µ ÀÌÁö¿¬ 2020-12-08 101
80 [´ëÇѾà»çÀú³Î] È£ÁÖ ¾à±¹ÀÇ Ä¡¸Å Äɾî Àü·«Àº? ÀÌÁö¿¬ 2020-12-01 112
79 [¾à»ç°ø·Ð] Ä¡¸Å±¹°¡Ã¥ÀÓÁ¦ '¿Ö ¾à»ç´Â ºüÁ³À»±î'¡¦¿Ü±¹Àº ¾î¶»°Ô? ±è¼±Èñ 2020-11-25 131
78 [µ¥Àϸ®ÆÊ] ³â µÚ Ä¡¸ÅÀα¸ 100¸¸ ½Ã´ë¡¦¾à±¹ ¿ªÇÒÀ» ã¾Æ¶ó ±è¼±Èñ 2020-11-25 131

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»